非小细胞肺癌EGFR外显子20插入突变检测和靶向药物研究进展

por WANG, Yulu, CHU, Tianqing
Publicado 2023

Mining GEO and TCGA Database for Immune Microenvironment of Lung Squamous Cell Carcinoma Patients With or Without Chemotherapy

por Qiang, Huiping, Li, Jiaqi, Chang, Qing, Shen, Yinchen, Qian, Jialin, Chu, Tianqing
Publicado 2022

Serum dickkopf-1 as a clinical and prognostic factor in non-small cell lung cancer patients with bone metastases

por Qiao, Rong, Zhong, Runbo, Chang, Qing, Teng, Jiajun, Pei, Jun, Han, Baohui, Chu, Tianqing
Publicado 2017

Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer

por Chen, Dongfang, Xu, Jianlin, Qiao, Rong, Zhao, Yizhuo, Chu, Tianqing, Han, Baohui, Zhong, Runbo
Publicado 2020

Clinical Features and Outcomes Analysis of Surgical Resected Pulmonary Large-Cell Neuroendocrine Carcinoma With Adjuvant Chemotherapy

por Shen, Yinchen, Hu, Fang, Li, Changhui, Xu, Jianlin, Zhong, Runbo, Zhang, Xueyan, Chu, Tianqing, Han, Baohui
Publicado 2020

Use of capture-based next-generation sequencing to detect ALK fusion in plasma cell-free DNA of patients with non-small-cell lung cancer

por Cui, Shaohua, Zhang, Wei, Xiong, Liwen, Pan, Feng, Niu, Yanjie, Chu, Tianqing, Wang, Huimin, Zhao, Yizhuo, Jiang, Liyan
Publicado 2016

Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell...

por Li, Jiaqi, Chen, Yingjie, Hu, Fan, Qiang, Huiping, Chang, Qing, Qian, Jialin, Shen, Yinchen, Cai, Yong, Chu, Tianqing
Publicado 2022

Feasibility of continuing crizotinib therapy after RECIST-PD in advanced non-small cell lung cancer patients with ALK/ROS-1 mutations

por Liu, Jun, Cui, Shaohua, Pan, Feng, Ni, Yiqian, Zhong, Hua, Xiong, Liwen, Jin, Bo, Chu, Tianqing, Gu, Aiqin, Jiang, Liyan
Publicado 2018

Serum TNFRII: A promising biomarker for predicting the risk of subcentimetre lung adenocarcinoma

por Hu, Minjuan, Zhang, Yanwei, Sun, Beibei, Lou, Yuqing, Zhang, Xueyan, Wang, Huimin, Huang, Chengya, Zhang, Wei, Chu, Tianqing, Han, Baohui
Publicado 2020

Does surgically resected small‐cell lung cancer without lymph node involvement benefit from prophylactic cranial irradiation?

por Lou, Yuqing, Zhong, Runbo, Xu, Jianlin, Qiao, Rong, Teng, Jiajun, Zhang, Yanwei, Zhang, Xueyan, Chu, Tianqing, Zhong, Hua, Han, Baohui
Publicado 2020

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients

por Zhang, Yanwei, Sun, Beibei, Hu, Minjuan, Lou, Yuqing, Lu, Jun, Zhang, Xueyan, Wang, Huimin, Qian, Jialin, Chu, Tianqing, Han, Baohui
Publicado 2020

Epidermal Growth Factor Receptor Mutation Status and Response to Tyrosine Kinase Inhibitors in Advanced Chinese Female Lung Squamous Cell Carcinoma: A Retrospective Study

por Chang, Qing, Qiang, Huiping, Qian, Jialin, Lei, Yuqiong, Lu, Jiahuan, Feng, Hui, Zhao, Yiming, Han, Baohui, Zhang, Yanwei, Chu, Tianqing
Publicado 2021

Paclitaxel Has a Reduced Toxicity Profile in Healthy Rats After Polymeric Micellar Nanoparticle Delivery

por Lu, Jun, Lou, Yuqing, Zhang, Yanwei, Zhong, Runbo, Zhang, Wei, Zhang, Xueyan, Wang, Huimin, Chu, Tianqing, Han, Baohui, Zhong, Hua
Publicado 2023

Potential Antitumor Activity of SIM-89 in Non-Small Cell Lung Cancer Cells

por Pei, Jun, Chu, Tianqing, Shao, Minhua, Teng, Jiajun, Sha, Huifang, Gu, Aiqing, Li, Rong, Qian, Jialin, Mao, Weifeng, Li, Ying, Han, Baohui
Publicado 2017

LPS inactivation by a host lipase allows lung epithelial cell sensitization for allergic asthma

por Qian, Guojun, Jiang, Wei, Zou, Benkun, Feng, Jintao, Cheng, Xiaofang, Gu, Jie, Chu, Tianqing, Niu, Chen, He, Rui, Chu, Yiwei, Lu, Mingfang
Publicado 2018

Effective low-dose Anlotinib induces long-term tumor vascular normalization and improves anti-PD-1 therapy

por Fan, Peng, Qiang, Huiping, Liu, Zhenhua, Zhao, Qi, Wang, Ying, Liu, Tingkun, Wang, Xuan, Chu, Tianqing, Huang, Yuhui, Xu, Wei, Qin, Songbing
Publicado 2022

Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data update

por Lu, Jun, Chu, Tianqing, Liu, Hongyu, Hu, Minjuan, Lou, Yuqing, Zhang, Yanwei, Gao, Zhiqiang, Zhang, Wei, Zhang, Xueyan, Wang, Huimin, Zhong, Hua, Han, Baohui
Publicado 2022

On-treatment lung immune prognostic index is predictive for first-line PD-1 inhibitor combined with chemotherapy in patients with non-small cell lung cancer

por Xiong, Anning, Xu, Jianlin, Wang, Shuyuan, Zhong, Runbo, Lu, Jun, Chu, Tianqing, Zhang, Wei, Li, Ying, Zheng, Xiaoxuan, Han, Baohui, Nie, Wei, Zhong, Hua, Zhang, Xueyan
Publicado 2023

Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy

por Yu, Xin, Li, Jiaqi, Ye, Lingyun, Zhao, Jing, Xie, Mengqing, Zhou, Juan, Shen, Yinchen, Zhou, Fei, Wu, Yan, Han, Chaonan, Qian, Jialin, Chu, Tianqing, Su, Chunxia
Publicado 2021

Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: a prospective and...

por Zhang, Bo, Shi, Chunlei, Gao, Zhiqiang, Zhong, Hua, Xiong, Liwen, Gu, Aiqin, Wang, Weimin, Chu, Tianqing, Zhang, Wei, Wang, Huimin, Zhang, Xueyan, Zhong, Runbo, Han, Baohui
Publicado 2022